BriaCell Therapeutics Corp. (BCTX) Stock Skyrockets Following Disclosure of Overall Survival (OS) Reports
BriaCell Therapeutics Corp. (BCTX) stock prices were down by a marginal 2.75% as of the market closing on June 1st, 2021, bringing the price per share up to USD$3.18 at the end of the trading day. Subsequent current market fluctuations have seen the stock skyrocket by 99.69% to hit USD$6.35. OS Update The clinical stage […]
